AN EUROPEAN OVERVIEW OF THE FUTURE CHANGES IN EVIDENCE REQUIREMENTS FOR THE REIMBURSEMENT OF ORPHAN DRUGS-A STAKEHOLDER ANALYSIS
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1377
https://www.valueinhealthjournal.com/article/S1098-3015(14)01428-4/fulltext
Title :
AN EUROPEAN OVERVIEW OF THE FUTURE CHANGES IN EVIDENCE REQUIREMENTS FOR THE REIMBURSEMENT OF ORPHAN DRUGS-A STAKEHOLDER ANALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01428-4&doi=10.1016/j.jval.2014.03.1377
First page :
A236
Section Title :
Systemic Disorders/Conditions
Open access? :
No
Section Order :
851